Clinical Trial Update: Peg-interferon for Inactive Chronic Hepatitis B Carriers [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update reports completion of Phase 2/3 studies of pegylated interferon for inactive hepatitis B carriers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Peg-interferon (pegylated interferon alfa)

Snippet

Sponsor: Seng Gee Lim | Conditions: Chronic Hepatitis, B Virus, Carrier of Viral Hepatitis Type B | Phase 2, Phase 3 | Status: COMPLETED